Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01280500 · ClinicalTrials.gov registry record · NA

Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN

A NA study of Asthma, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
1,040
Enrollment target
2
Study locations

NCT01280500: Completed NA study of Asthma, sponsored by Wake Forest University Health Sciences.

NCT01280500 is a NA study of Asthma that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,040 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (33% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01280500, a NA study of Asthma, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
1,040 participants
Enrollment target
2
Study locations

Study Summary

The overall goal is to identify best practices for improving health outcomes for patients with asthma using comparative effectiveness research within an Agency for Healthcare Research and Quality (AHRQ) Practice-Based Research Network (PBRN). This goal will be achieved by completing the following aims: (1) Create a centralized database for comparative effectiveness research on asthma by combining clinical and billing data from one of the largest healthcare systems in the country (Carolinas Healthcare System) with data from the school system, Medicaid, and patient and community-level datasets; (2) Deploy a fully developed integrated approach to asthma management based on the Chronic Care Model; (3) Develop and implement a "shared decision making" approach for asthmatic patients from disadvantaged backgrounds; (4) Implement an electronic data collection system for an existing CDC funded school-based asthma intervention that will allow program evaluation and link school nurses with providers; (5) Evaluate and compare the effectiveness of these three asthma management strategies on: overall healthcare consumption and medical costs; quality of life, school absenteeism and performance; asthma clinical measures; and medication utilization; and (6) Disseminate findings across the state via the statewide PBRN and other network partners. This project has the potential to impact over 30,000 asthma patients across the Carolinas including many patients from disadvantaged backgrounds.

Primary Outcome

Quality goals will be measured by the percentage of patients who reach the goal out of all patients identified with the disease through healthcare system data.

Conditions Studied

Interventions

  • OTHER usual care
  • BEHAVIORAL electronic medical record
  • OTHER Integrated Approach to Care
  • OTHER Shared Decision Making
  • OTHER school based care

Study Locations (2)

North Carolina

  • CMC Elizabeth Family Medicine - Charlotte
  • Department of Family Medicine - Charlotte

Trial Details

FieldValue
Enrollment Target 1,040 participants
Start Date 2011-03
Est. Completion 2017-08
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01280500 record still lists

NCT01280500 is an interventional study that assigns participants to a tested intervention. Its 1,040 participants enrollment target places it among the larger protocols in the corpus, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (33% lower).

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 5 interventions - of which usual care is the first listed.

NCT01280500 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01280500 about?

NCT01280500 is a clinical study titled "Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN". The overall goal is to identify best practices for improving health outcomes for patients with asthma using comparative effectiveness research within an Agency for Healthcare Research and Quality (AHRQ) Practice-Based Research Network (PBRN). This goal will be achieved by completing the following ai...

What is the current status of trial NCT01280500?

This trial is currently completed. It is a NA study. The enrollment target is 1,040 participants. The study started on 2011-03. Estimated completion is 2017-08.

What conditions does trial NCT01280500 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT01280500?

The interventions under investigation include: usual care (OTHER), electronic medical record (BEHAVIORAL), Integrated Approach to Care (OTHER), Shared Decision Making (OTHER), school based care (OTHER).

Who is sponsoring clinical trial NCT01280500?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01280500 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01280500's enrollment target sits among peer trials

1,040 40th of 374 higher than 335 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05219110 · 1,040 participants · NA

    Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

  • NCT06564948 · 1,040 participants · NA

    Treatment for Individuals Interacting with the Criminal Justice System

  • NCT06661720 · 1,040 participants · Phase 3

    Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • NCT04685616 · 1,042 participants · Phase 3

    Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01280500, the US trial registry maintained by the National Library of Medicine. NCT01280500 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.